Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Global Radiation Oncology Market 2009-2013 | Feb 2010 | £950 | 100% |
| Global Radiation Oncology Market 2009-2013 |
Feb 2010 | £950 | 99% |
| DNA Diagnostics: Technologies and Global Markets | Jan 2008 | £3,065 | 86% |
| Monoclonal Antibodies Report | Jun 2008 | £4,805 | 84% |
| Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 |
Dec 2010 | £1,895 | 81% |
| Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020 |
Dec 2010 | £1,895 | 81% |
| Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020 |
Dec 2010 | £1,895 | 81% |
| Pancreatic Cancer Pipeline Assessment and Market Forecasts to 2017 |
Nov 2010 | £1,265 | 81% |
| Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020 | Oct 2011 | £1,265 | 79% |
| Threats to Avastin Targeting the VEGF Pathway |
Apr 2010 | £1,295 | 79% |
| Biologic Imaging Reagents: Technologies and Global Markets | Dec 2008 | £3,065 | 77% |
| Eisai: Pipeline, Products, Performance, Potential | Nov 2009 | £595 | 77% |
| Tarceva Analysis and Market Forecasts from 2013 to 2020 |
Jul 2011 | £1,265 | 77% |
| Brivanib Analysis and Market Forecasts from 2013 to 2020 |
Jul 2011 | £1,265 | 77% |
| Linifanib Assessment and Market Forecasts from 2013 to 2020 |
Jul 2011 | £1,265 | 77% |
| New Drug Futures 2009 | Jan 2012 | £1,995 | 77% |
| Global Pharmaceutical Biotech Market 2010-2025 Market growth, novel technologies and expansion into new therapeutic areas |
Dec 2009 | £1,499 | 77% |
| Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020 |
Dec 2010 | £1,895 | 76% |
| Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020 |
Dec 2010 | £1,895 | 76% |
| Global Invitro Diagnostics Market 2009-2013 | Feb 2010 | £950 | 76% |
| Amgen Inc.: PharmaVitae Profile Healthcare |
Mar 2009 | £3,605 | 75% |
| Patient Monitoring Markets | Oct 2009 | £2,150 | 75% |
| ThermoDox Analysis and Market Forecasts from 2012 to 2020 |
Jul 2011 | £1,265 | 75% |
| Botanical and Plant-Derived Drugs: Global Markets | Jan 2009 | £3,065 | 75% |
| Therapeutic Monoclonal Antibodies Markets | Jun 2009 | £1,265 | 74% |
| Talactoferrin Alfa (NSCLC) Analysis and Forecasts to 2020 |
Oct 2011 | £1,265 | 74% |
| Worldwide Point of Care Diagnostic Test Markets | Dec 2010 | £1,770 | 72% |
| The Clinical Laboratory Services Market Growth Opportunities, Competitive Analysis and Competitor Profiles |
Feb 2010 | £2,215 | 72% |
| Votrient (Ovarian Cancer) – Analysis and Forecasts to 2020 | Oct 2011 | £1,265 | 72% |
| Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020 | Oct 2011 | £1,265 | 71% |
